SCHEMBL6167929

SCHEMBL6167929

O=C(O)Cc1onc2cc(Br)ccc12

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AURKA O14965 2/20 0.39
AURKB Q96GD4 2/20 0.39
KDR P35968 1/20 0.39
AKR1B1 P15121 6/20 0.37
PTPN1 P18031 1/20 0.36
MAPT P10636 1/20 0.36
PTGS1 P23219 1/20 0.36
PTGS2 P35354 1/20 0.36
PDE3A Q14432 1/20 0.36
SLC22A12 Q96S37 1/20 0.36
MEN1 O00255 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
KMT2A Q03164 1/20 0.35
HSD17B10 Q99714 1/20 0.35
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
GAA P10253 1/20 0.34
GPR17 Q13304 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6169729 0.82 LMNA (0.38) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL6169257 0.80 RXFP1 (0.50) MEN1KMT2AKDM4EALDH1A1
SCHEMBL6167002 0.79 SMN1; SMN2 (0.40) MAPTPTGS2KDM4EALDH1A1
SCHEMBL6169278 0.77 LMNA (0.42) PTGS2KMT2AALDH1A1
SCHEMBL1027461 0.77 SMN1; SMN2 (0.43) AKR1B1MAPTPTGS1PTGS2PDE3A
SCHEMBL30314714 0.77 MEN1 (0.38) MAPTPTGS1PTGS2MEN1CYP1A2
SCHEMBL6170078 0.76 KMT2A (0.42) MAPTMEN1CYP1A2CYP2C9KMT2A
SCHEMBL17438051 0.76 PTPN1 (0.42) PTPN1MAPTSLC22A12MEN1KMT2A
SCHEMBL3524883 0.72 MAPT (0.56) AKR1B1MAPTMEN1CYP1A2CYP2C9
SCHEMBL11203269 0.72 ALDH1A1 (0.49) AKR1B1MAPTMEN1CYP2C9KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1531812-A1 FUSED HETEROARYL DERIVATIVES FOR USE AS P38 KINASE INHIBITORS IN THE TREATMENT OF I.A. RHEUMATOID ARTHRISTIS SMITHKLINE BEECHAM CORPORATION (US) 2005-05-25 EP disclosed
WO-2004010995-A1 FUSED HETEROARYL DERIVATIVES FOR USE AS P38 KINASE INHIBITORS IN THE TREATMENT OF I.A. RHEUMATOID ARTHRISTIS SMITHKLINE BEECHAM CORPORATION (US) 2004-02-05 WO disclosed